BERLIN, Germany and ATLANTA, Georgia, September 26, 2023 / B3C newswire / ProBioGen and GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing vaccines and immunotherapies against infectious diseases and cancers, announce the signing of a landmark commercial license agreement for ProBioG.
BOSTON, MA, USA and BERLIN, Germany, May 17, 2023 / B3C newswire / ProBioGen today announced the launch of their lentivirus (LV) packaging cell line Lenti.RiGHT™ as a new platinum standard for LV production at this year's PEGS Boston 2023. The lentivirus production platform is based on HEK293 packaging cells.
BERLIN, Germany, March 30, 2023 / B3C newswire / ProBioGen, the Berlin-based CDMO and technology provider, reported today that revenues for the fiscal year 2022 (FY22) grew 35% vs FY21.In a year marked by new geopolitical and macroeconomic challenges, ProBioGen was able to carry on its rapid growth trajector.
Julian Collins, Jana Windt and Michiel Stork Join Biopharma Company’s Leadership TeamBERLIN, Germany, March 02, 2023 / B3C newswire / ProBioGen has seen significant growth with over 300 employees now working across its three locations in Berlin. In line with this growth, three crucial positions have been filled..